Predicate |
Object |
contentType |
Journal Article |
endingPage |
402 |
issn |
1948-5875 |
issueIdentifier |
5 |
pageRange |
401-402 |
publicationName |
ACS Medicinal Chemistry Letters |
startingPage |
401 |
bibliographicCitation |
Kargbo RB. 2,7-Diazaspiro[4,4]nonanes for the Treatment or Prevention of Cancers and Diabetes. ACS Med. Chem. Lett. 2018 Apr 13;9(5):401–2. doi: 10.1021/acsmedchemlett.8b00159. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5539-6343 |
date |
2018-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC5949728 https://doi.org/10.1021/acsmedchemlett.8b00159 https://pubmed.ncbi.nlm.nih.gov/29795748 |
isPartOf |
https://portal.issn.org/resource/ISSN/1948-5875 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
2,7-Diazaspiro[4,4]nonanes for the Treatment or Prevention of Cancers and Diabetes |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 |